Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald D Rao

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 27, 2015
Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory CancerMinal Barve, Zhaohui Wang, Padmasini Kumar, et al.
Plos One|August 21, 2012
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platformShi-He Liu, Donald D Rao, John Nemunaitis, et al.
DNA and Cell Biology|May 27, 2011
In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoproteinAnagha P Phadke, Chris M Jay, Zhaohui Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancerNeil Senzer, Minal Barve, Joseph Kuhn, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 27, 2015
Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory CancerMinal Barve, Zhaohui Wang, Padmasini Kumar, et al.
Plos One|August 21, 2012
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platformShi-He Liu, Donald D Rao, John Nemunaitis, et al.
DNA and Cell Biology|May 27, 2011
In vivo safety and antitumor efficacy of bifunctional small hairpin RNAs specific for the human Stathmin 1 oncoproteinAnagha P Phadke, Chris M Jay, Zhaohui Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2011
Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell" vaccine (FANG) in advanced cancerNeil Senzer, Minal Barve, Joseph Kuhn, et al.
Pageof 2